The Correlation Between sP-Selectin and Platelet Count in COVID-19 Patients in Referral Hospital, West Java Indonesia

References

• Tahmineh Mokhtari FH, Ghaffari N, Ghaffari N, et al. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. 2020;51(6):613–628. doi:10.1007/s10735-020-09915-3
   PubMed Web of Science ®Google Scholar
• Mohammad Madjid PS-N, Solomon SD, Solomon SD, et al. Potential effects of coronaviruses on the cardiovascular system. JAMA Cardiol. 2020;5(7):831–840. doi:10.1001/jamacardio.2020.1286
   PubMed Web of Science ®Google Scholar
• Agrati C, Bordoni V, Sacchi A, et al. Elevated P-selectin in severe Covid-19: considerations for therapeutic options. Mediterr J Hematol Infect Dis. 2021;13(1):e2021016. doi:10.4084/mjhid.2021.016
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis M, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS Coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. doi:10.1002/path.1570
   PubMed Web of Science ®Google Scholar
• Freedman JE, Lascalzo J. Platelets and fibrinolysis/thrombolysis. Fibrinolysis in Disease Molecular and Hemovascular Aspects of Fibrinolysis. CRC; 2019:65–69.
   Google Scholar
• Varga Z, Flammer AJ, Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5
   PubMed Web of Science ®Google Scholar
• Lopez-Castaneda S, García-Larragoiti N, Cano-Mendez A, et al. Inflammatory and prothrombotic biomarkers associated with the severity of COVID-19 infection. Clin Appl Thromb Hemost. 2021;27:1–9.
   Web of Science ®Google Scholar
• Tommaso Neri DN, Celi A, Celi A. P-selectin blockade in COVID-19 related ARDS. Am J Physiol Lung Cell Mol Physiol. 2020;318(6):L1237–L1238. doi:10.1152/ajplung.00202.2020
   PubMed Web of Science ®Google Scholar
• Alicja Polek WS, Matowicka-Karna J. P-Selectin and Its Role in Some Diseases. Postepy Hig Med Dosw. 2009;63:465–470.
   Web of Science ®Google Scholar
• Corlia Grobler SC, Maphumulo SC, Grobbelaar LM, et al. COVID-19: the Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci. 2020;21(14):5168. doi:10.3390/ijms21145168
   PubMed Web of Science ®Google Scholar
• López Reboiro ML, Suárez Fuentetaja R, Gutiérrez López R, et al. Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19. J Infect. 2021;82(6):e27–e28. doi:10.1016/j.jinf.2021.03.006
   PubMed Web of Science ®Google Scholar
• Ming Chen M, Geng J-G. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp. 2006;54(2):75–84. doi:10.1007/s00005-006-0010-6
   PubMed Web of Science ®Google Scholar
• Nader Yatim JB, Chocron R, Chocron R. Platelet Activation in Critically Ill COVID-19 Patients. Ann Intensive Care. 2021;11(1):113. doi:10.1186/s13613-021-00899-1
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020;31(4):490–496. doi:10.1080/09537104.2020.1754383
   PubMed Web of Science ®Google Scholar
• Litao Zhang XY, Fan Q, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1324–1329. doi:10.1111/jth.14859
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al.; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950–2973. doi:10.1016/j.jacc.2020.04.031
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al.; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:10.1007/s00134-020-06062-x
   PubMed Web of Science ®Google Scholar
• Wool G, Miller D, J L. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology. 2021;88(1):15–27. doi:10.1159/000512007
   PubMed Web of Science ®Google Scholar
• Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1469–1472. PMID: 32302435. doi:10.1111/jth.14848
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148. PMID: 32178975; PMCID: PMC7102663. doi:10.1016/j.cca.2020.03.022
   PubMed Web of Science ®Google Scholar
• Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317–1329. doi:10.1182/blood.2020007214
   PubMed Web of Science ®Google Scholar
• Blann AD, Nadar SK, Lip GYH. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 2003;24(24):2166–2179. doi:10.1016/j.ehj.2003.08.021
   PubMed Web of Science ®Google Scholar
• Pakala R, Waksman R. Currently available methods for platelet function analysis: advantages and disadvantages. Cardiovasc Revascular Med. 2011;12(5):312–322. doi:10.1016/j.carrev.2010.09.005
   PubMedGoogle Scholar